Editorial: Appropriate Use Recommendations for Lecanemab
J Prev Alzheimers Dis
.
2023;10(3):356.
doi: 10.14283/jpad.2023.34.
Author
M S Rafii
1
Affiliation
1
Michael S. Rafii, Alzheimer's Therapeutic Research Institute, Keck School of Medicine of the University of Southern California, USA,
[email protected]
.
PMID:
37357273
DOI:
10.14283/jpad.2023.34
No abstract available
Publication types
Editorial
Comment
MeSH terms
Biomedical Research*
Humans
Information Dissemination*
Substances
lecanemab